US Stock MarketDetailed Quotes

RIGL Rigel Pharmaceuticals

Watchlist
  • 13.630
  • -0.640-4.48%
Close Oct 31 16:00 ET
  • 13.630
  • 0.0000.00%
Post 20:01 ET
239.82MMarket Cap-17701P/E (TTM)

Rigel Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
37.03%36.84M
13.29%29.53M
-2.79%116.88M
-30.20%35.79M
25.54%28.13M
-9.84%26.89M
55.78%26.07M
-19.43%120.24M
151.25%51.28M
4.02%22.41M
Operating revenue
43.64%52.37M
18.11%41.96M
5.00%159.65M
-21.19%48.07M
31.10%39.59M
22.27%36.46M
112.27%35.52M
-9.18%152.05M
58.08%61M
40.18%30.2M
Cost of revenue
161.12%2.81M
107.27%2.03M
306.52%7.11M
1,008.19%3.79M
407.20%1.27M
3.76%1.08M
707.44%977K
61.50%1.75M
-29.77%342K
65.56%250K
Gross profit
31.86%34.03M
9.63%27.51M
-7.36%109.77M
-37.17%32M
21.24%26.87M
-10.33%25.81M
51.04%25.09M
-20.02%118.49M
155.68%50.94M
3.59%22.16M
Operating expense
8.07%33.59M
-8.84%34.48M
-24.58%130.26M
-36.82%30.04M
-22.76%31.33M
-25.56%31.08M
-11.79%37.82M
9.93%172.72M
25.70%47.54M
-1.49%40.56M
Selling and administrative expenses
6.62%28.05M
2.60%28.45M
-5.97%105.74M
-16.54%26.85M
-4.02%24.86M
-2.50%26.31M
1.20%27.73M
22.37%112.45M
31.23%32.17M
13.20%25.9M
Research and development costs
16.09%5.54M
-40.27%6.03M
-59.31%24.52M
-79.26%3.19M
-55.85%6.48M
-67.68%4.77M
-34.80%10.09M
-7.61%60.27M
15.49%15.37M
-19.86%14.67M
Operating profit
108.49%447K
45.26%-6.97M
62.21%-20.49M
-42.16%1.97M
75.74%-4.47M
59.38%-5.27M
51.54%-12.73M
-504.23%-54.23M
118.99%3.4M
6.99%-18.4M
Net non-operating interest income expense
-10.80%-1.48M
-57.95%-1.28M
-52.17%-4.6M
-81.27%-1.23M
-93.53%-1.23M
-152.94%-1.33M
31.50%-811K
37.19%-3.02M
47.16%-678K
51.34%-634K
Non-operating interest income
4.35%552K
50.89%593K
232.16%2.27M
58.04%678K
250.00%672K
1,159.52%529K
1,771.43%393K
1,355.32%684K
2,581.25%429K
1,271.43%192K
Non-operating interest expense
8.97%2.03M
55.65%1.87M
85.38%6.87M
72.27%1.91M
129.90%1.9M
227.24%1.86M
-0.08%1.2M
-23.72%3.71M
-14.78%1.11M
-37.28%826K
Other net income (expense)
62.51%-1.32M
Special income (charges)
----
----
--0
----
----
----
----
62.51%-1.32M
----
----
-Less:Restructuring and merger&acquisition
----
----
--0
----
----
----
----
-62.51%1.32M
----
----
Income before tax
84.39%-1.03M
39.07%-8.25M
57.16%-25.09M
-47.39%737K
70.10%-5.69M
51.08%-6.6M
50.68%-13.54M
-238.40%-58.57M
106.17%1.4M
9.73%-19.04M
Income tax
0
0
Net income
84.39%-1.03M
39.07%-8.25M
57.16%-25.09M
-47.39%737K
70.10%-5.69M
51.08%-6.6M
50.68%-13.54M
-226.97%-58.57M
106.19%1.4M
9.14%-19.04M
Net income continuous Operations
84.39%-1.03M
39.07%-8.25M
57.16%-25.09M
-47.39%737K
70.10%-5.69M
51.08%-6.6M
50.68%-13.54M
-226.97%-58.57M
106.19%1.4M
9.14%-19.04M
Minority interest income
Net income attributable to the parent company
84.39%-1.03M
39.07%-8.25M
57.16%-25.09M
-47.39%737K
70.10%-5.69M
51.08%-6.6M
50.68%-13.54M
-226.97%-58.57M
106.19%1.4M
9.14%-19.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
84.39%-1.03M
39.07%-8.25M
57.16%-25.09M
-47.39%737K
70.10%-5.69M
51.08%-6.6M
50.68%-13.54M
-226.97%-58.57M
106.19%1.4M
9.14%-19.04M
Basic earnings per share
84.21%-0.06
37.50%-0.5
58.82%-1.4
0.00%0.1
72.73%-0.3
52.50%-0.38
50.00%-0.8
-209.09%-3.4
107.69%0.1
8.33%-1.1
Diluted earnings per share
84.21%-0.06
37.50%-0.5
58.82%-1.4
0.00%0.1
72.73%-0.3
52.50%-0.38
50.00%-0.8
-209.09%-3.4
107.69%0.1
8.33%-1.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 37.03%36.84M13.29%29.53M-2.79%116.88M-30.20%35.79M25.54%28.13M-9.84%26.89M55.78%26.07M-19.43%120.24M151.25%51.28M4.02%22.41M
Operating revenue 43.64%52.37M18.11%41.96M5.00%159.65M-21.19%48.07M31.10%39.59M22.27%36.46M112.27%35.52M-9.18%152.05M58.08%61M40.18%30.2M
Cost of revenue 161.12%2.81M107.27%2.03M306.52%7.11M1,008.19%3.79M407.20%1.27M3.76%1.08M707.44%977K61.50%1.75M-29.77%342K65.56%250K
Gross profit 31.86%34.03M9.63%27.51M-7.36%109.77M-37.17%32M21.24%26.87M-10.33%25.81M51.04%25.09M-20.02%118.49M155.68%50.94M3.59%22.16M
Operating expense 8.07%33.59M-8.84%34.48M-24.58%130.26M-36.82%30.04M-22.76%31.33M-25.56%31.08M-11.79%37.82M9.93%172.72M25.70%47.54M-1.49%40.56M
Selling and administrative expenses 6.62%28.05M2.60%28.45M-5.97%105.74M-16.54%26.85M-4.02%24.86M-2.50%26.31M1.20%27.73M22.37%112.45M31.23%32.17M13.20%25.9M
Research and development costs 16.09%5.54M-40.27%6.03M-59.31%24.52M-79.26%3.19M-55.85%6.48M-67.68%4.77M-34.80%10.09M-7.61%60.27M15.49%15.37M-19.86%14.67M
Operating profit 108.49%447K45.26%-6.97M62.21%-20.49M-42.16%1.97M75.74%-4.47M59.38%-5.27M51.54%-12.73M-504.23%-54.23M118.99%3.4M6.99%-18.4M
Net non-operating interest income expense -10.80%-1.48M-57.95%-1.28M-52.17%-4.6M-81.27%-1.23M-93.53%-1.23M-152.94%-1.33M31.50%-811K37.19%-3.02M47.16%-678K51.34%-634K
Non-operating interest income 4.35%552K50.89%593K232.16%2.27M58.04%678K250.00%672K1,159.52%529K1,771.43%393K1,355.32%684K2,581.25%429K1,271.43%192K
Non-operating interest expense 8.97%2.03M55.65%1.87M85.38%6.87M72.27%1.91M129.90%1.9M227.24%1.86M-0.08%1.2M-23.72%3.71M-14.78%1.11M-37.28%826K
Other net income (expense) 62.51%-1.32M
Special income (charges) ----------0----------------62.51%-1.32M--------
-Less:Restructuring and merger&acquisition ----------0-----------------62.51%1.32M--------
Income before tax 84.39%-1.03M39.07%-8.25M57.16%-25.09M-47.39%737K70.10%-5.69M51.08%-6.6M50.68%-13.54M-238.40%-58.57M106.17%1.4M9.73%-19.04M
Income tax 00
Net income 84.39%-1.03M39.07%-8.25M57.16%-25.09M-47.39%737K70.10%-5.69M51.08%-6.6M50.68%-13.54M-226.97%-58.57M106.19%1.4M9.14%-19.04M
Net income continuous Operations 84.39%-1.03M39.07%-8.25M57.16%-25.09M-47.39%737K70.10%-5.69M51.08%-6.6M50.68%-13.54M-226.97%-58.57M106.19%1.4M9.14%-19.04M
Minority interest income
Net income attributable to the parent company 84.39%-1.03M39.07%-8.25M57.16%-25.09M-47.39%737K70.10%-5.69M51.08%-6.6M50.68%-13.54M-226.97%-58.57M106.19%1.4M9.14%-19.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 84.39%-1.03M39.07%-8.25M57.16%-25.09M-47.39%737K70.10%-5.69M51.08%-6.6M50.68%-13.54M-226.97%-58.57M106.19%1.4M9.14%-19.04M
Basic earnings per share 84.21%-0.0637.50%-0.558.82%-1.40.00%0.172.73%-0.352.50%-0.3850.00%-0.8-209.09%-3.4107.69%0.18.33%-1.1
Diluted earnings per share 84.21%-0.0637.50%-0.558.82%-1.40.00%0.172.73%-0.352.50%-0.3850.00%-0.8-209.09%-3.4107.69%0.18.33%-1.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data